InvestorsHub Logo
Followers 13
Posts 4329
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 7:36:11 PM

Monday, November 16, 2020 7:36:11 PM

Post# of 18220
Immune Therapeutics Inc.'s platform is built on two different immunotherapies, Low Dose Naltrexone (LDN) and Methionine-Enkephalin (MENK). Both therapies have been decades in the making at institutions such as the Pennsylvania State University Medical School at Hershey, University of Chicago, State University of New York, and Multiple Sclerosis Center at UCSF.$IMUN